Presentation TVT 2023 The Next Generation of LAAC Device and Tailored Therapy Presenter: Saibal Kar June 09, 2023
Presentation THT 2023 Will Gene Therapy With CRISPR Cure ATTR-CA? Presenter: Ahmad Masri March 21, 2023
Presentation THT 2023 MIRTH: Myocardial Intramural Remodeling by Transvenous Tether Presenter: Adam Greenbaum March 21, 2023
Presentation THT 2023 Biological vs Physical Reverse Remodeling: Implications for Device-Based Therapies for HFrEF Presenter: Michael Brener March 21, 2023
Presentation THT 2023 DHF: Who Is Beyond Medical Therapy and in Need of a Device? Presenter: Ulrich Jorde March 20, 2023
Presentation THT 2023 Applications of Gene Therapy in Cardiomyopathies (TBD) Presenter: Eric Adler March 20, 2023
Presentation THT 2023 Re-Poll: Revascularization or Medical Therapy? Presenter: Dor Lotan March 20, 2023
Presentation THT 2023 Poll: Revascularization or Medical Therapy? Presenter: Dor Lotan March 20, 2023
Presentation THT 2023 Assessing the Residual Risk: What Gaps Should New Technologies Fill? Presenter: Javed Butler March 20, 2023
Presentation THT 2023 The AI Revolution and How It Is Impacting Health Care Delivery in Heart Failure Presenter: Nir Uriel March 20, 2023
Presentation THT 2023 Recent Advances in the Medical Treatment of Patients With Decompensated Heart Failure Presenter: Alexandre Mebazaa March 20, 2023
Presentation THT 2023 Contemporary Implementation of Guideline-Directed Therapy for Heart Failure Presenter: Gad Cotter March 20, 2023
Presentation THT 2023 SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits Presenter: Milton Packer March 20, 2023
Presentation THT 2023 The Impact of SGLT2 Inhibitors Across the Spectrum of Heart Failure Presenter: Scott Solomon March 20, 2023
Presentation THT 2023 Opening Talk: Innovation and Technologies to Enhance the Care of Patients With Heart Failure Presenter: Daniel Burkhoff March 20, 2023